Suppr超能文献

在印度患有泰萨二氏病的儿童中鉴定 HEXA 基因突变。

Identification of novel mutations in HEXA gene in children affected with Tay Sachs disease from India.

机构信息

FRIGE Institute of Human Genetics, Ahmedabad, Gujarat, India.

出版信息

PLoS One. 2012;7(6):e39122. doi: 10.1371/journal.pone.0039122. Epub 2012 Jun 18.

Abstract

Tay Sachs disease (TSD) is a neurodegenerative disorder due to β-hexosaminidase A deficiency caused by mutations in the HEXA gene. The mutations leading to Tay Sachs disease in India are yet unknown. We aimed to determine mutations leading to TSD in India by complete sequencing of the HEXA gene. The clinical inclusion criteria included neuroregression, seizures, exaggerated startle reflex, macrocephaly, cherry red spot on fundus examination and spasticity. Neuroimaging criteria included thalamic hyperdensities on CT scan/T1W images of MRI of the brain. Biochemical criteria included deficiency of hexosaminidase A (less than 2% of total hexosaminidase activity for infantile patients). Total leukocyte hexosaminidase activity was assayed by 4-methylumbelliferyl-N-acetyl-β-D-glucosamine lysis and hexosaminidase A activity was assayed by heat inactivation method and 4-methylumbelliferyl-N-acetyl-β-D-glucosamine-6-sulphate lysis method. The exons and exon-intron boundaries of the HEXA gene were bidirectionally sequenced using an automated sequencer. Mutations were confirmed in parents and looked up in public databases. In silico analysis for mutations was carried out using SIFT, Polyphen2, MutationT@ster and Accelrys Discovery Studio softwares. Fifteen families were included in the study. We identified six novel missense mutations, c.340 G>A (p.E114K), c.964 G>A (p.D322N), c.964 G>T (p.D322Y), c.1178C>G (p.R393P) and c.1385A>T (p.E462V), c.1432 G>A (p.G478R) and two previously reported mutations. c.1277_1278insTATC and c.508C>T (p.R170W). The mutation p.E462V was found in six unrelated families from Gujarat indicating a founder effect. A previously known splice site mutation c.805+1 G>C and another intronic mutation c.672+30 T>G of unknown significance were also identified. Mutations could not be identified in one family. We conclude that TSD patients from Gujarat should be screened for the common mutation p.E462V.

摘要

泰萨二氏病(TSD)是一种神经退行性疾病,由 HEXA 基因突变导致β-己糖胺酶 A 缺乏引起。导致印度泰萨二氏病的突变尚不清楚。我们旨在通过完全测序 HEXA 基因来确定导致印度 TSD 的突变。临床纳入标准包括神经发育倒退、癫痫发作、惊跳反射过度、大头畸形、眼底樱桃红斑和痉挛。神经影像学标准包括脑 CT 扫描/磁共振成像 T1W 图像上的丘脑高密度。生化标准包括β-己糖胺酶 A 缺乏(婴儿患者总己糖胺酶活性的<2%)。总白细胞β-己糖胺酶活性通过 4-甲基伞形酮-N-乙酰-β-D-葡萄糖胺裂解测定,β-己糖胺酶 A 活性通过热失活法和 4-甲基伞形酮-N-乙酰-β-D-葡萄糖胺-6-硫酸盐裂解法测定。使用自动测序仪对 HEXA 基因的外显子和外显子-内含子边界进行双向测序。突变在父母中得到确认,并在公共数据库中查找。使用 SIFT、Polyphen2、MutationT@ster 和 Accelrys Discovery Studio 软件对突变进行了计算机分析。这项研究纳入了 15 个家庭。我们发现了六个新的错义突变,c.340 G>A(p.E114K)、c.964 G>A(p.D322N)、c.964 G>T(p.D322Y)、c.1178C>G(p.R393P)和 c.1385A>T(p.E462V)、c.1432 G>A(p.G478R)以及两个先前报道的突变 c.1277_1278insTATC 和 c.508C>T(p.R170W)。突变 p.E462V 存在于来自古吉拉特邦的六个无关家庭中,表明存在一个创始人效应。还发现了一个先前已知的剪接位点突变 c.805+1 G>C 和另一个外显子内突变 c.672+30 T>G,其意义不明。一个家庭的突变无法识别。我们得出结论,古吉拉特邦的 TSD 患者应筛查常见的突变 p.E462V。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d1/3377590/2a12e0637143/pone.0039122.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验